OREGOVOMAB
UNII HX101E7L6S

Substance Identification & Data

This profile provides standardized clinical and technical data for Oregovomab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HX101E7L6S.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 213327-37-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

HX101E7L6S

CAS Registry Number

213327-37-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OREGOVOMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C1784

National Cancer Institute reference terminology for clinical and research data.

INN ID

8183

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MM-87

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Oregovomab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OREGOVOMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN CA125 (CARBOHYDRATE ANTIGEN)) (MOUSE MONOCLONAL B43.13.GAMMA.1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL B43.13.KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN CA125 (CARBOHYDRATE ANTIGEN)) (MOUSE MONOCLONAL B43.13.GAMMA.1-CHAIN), DISULPHIDE WITH MOUSE MONOCLONAL B43.13.KAPPA.-CHAIN, DIMER

OREGOVOMAB [INN]

OREGOVOMAB [MI]

OREGOVOMAB [USAN]

OREGOVOMAB [WHO-DD]